...
机译:IDES(Imlifidase):一种新的剂,可切割人IgG并允许穿过高强度供体特异性抗体的成功肾移植
NYU Langone Hlth Transplant Inst New York NY USA;
NYU Langone Hlth Transplant Inst New York NY USA;
NYU Langone Hlth Transplant Inst New York NY USA;
NYU Langone Hlth Transplant Inst New York NY USA;
NYU Langone Hlth Transplant Inst New York NY USA;
NYU Langone Hlth Transplant Inst New York NY USA;
NYU Langone Hlth Transplant Inst New York NY USA;
NYU Langone Hlth Dept Med Div Nephrol New York NY USA;
NYU Langone Hlth Transplant Inst New York NY USA;
NYU Langone Hlth Dept Pathol New York NY USA;
NYU Langone Hlth Transplant Inst New York NY USA;
desensitization; HLA sensitization; incompatible kidney transplantation;
机译:IDES(Imlifidase):一种新的剂,可切割人IgG并允许穿过高强度供体特异性抗体的成功肾移植
机译:在肾移植受者的供体特异性抗人白细胞抗原抗体存在下成功脱敏和肾移植
机译:IgG在肾移植成功脱敏处理后的特异性抗HLA抗体亚类
机译:ABO-Indompative肾移植中的供体特异性抑制血型抗体
机译:小儿肾移植受者的EPLET不匹配和De Novo供体特异性抗体发育
机译:物理交叉比赛和虚拟交叉比赛的比较以确定肾脏移植后已存在的供体特异性人类白细胞抗原(HLA)抗体和结果
机译:物理交叉迁移和虚拟交叉靶的比较鉴定预先存在的供体性白细胞抗原(HLA)抗体和肾移植后的结果